Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can mindfulness together ease Parkinson's stress?

NCT ID NCT06821230

First seen Mar 20, 2026 · Last updated Jun 22, 2026 · Updated 13 times

Summary

This study tests whether 8 weeks of mindfulness classes, taken together by people with Parkinson's and their family caregivers, can reduce negative emotions like stress, anxiety, and depression. About 200 Chinese patient-caregiver pairs will either take the classes or continue usual care. Researchers will also check if the program improves their relationship, quality of life, and even gut health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MOVEMENT DISORDERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • School of Nursing, The University of Hong Kong

    RECRUITING

    Hong Kong, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dyadic mindfulness (behavioral intervention)

What this could lead to

If it works, this could offer a simple, drug-free way to ease emotional distress and strengthen the bond between people with Parkinson's and their caregivers.

What could go wrong

This is a small, early-stage study with only 200 participants, so results may not apply to everyone. The benefits may be modest or not last long-term.

Conditions

The condition(s) this trial relates to.

movement disorder neurodegenerative disease Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.